ReviewCritical reviews in toxicology2017
Origin of the TTC values for compounds that are genotoxic and/or carcinogenic and an approach for their re-evaluation.
Review in Critical reviews in toxicology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Principles of Food Safety and Toxicological Risk Assessment: Refining Hazards, Risk Management Communication, and Common Misconceptions.Comprehensive reviews in food science and food safety · 2026Review
- Guidelines for the assessment and control of mutagenic impurities in pharmaceuticals.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2025Review
- Editorial: Advances and Refinements in the Development and Application of Threshold of Toxicological Concern.Frontiers in toxicology · 2022Article
- Prioritization of chemicals in food for risk assessment by integrating exposure estimates and new approach methodologies: A next generation risk assessment case study.Frontiers in toxicology · 2022Article
- Deep neural network for the determination of transformed foci in Bhas 42 cell transformation assay.Scientific reports · 2021Article
- Defining the Human-Biota Thresholds of Toxicological Concern for Organic Chemicals in Freshwater: The Proposed Strategy of the LIFE VERMEER Project Using VEGA Tools.Molecules (Basel, Switzerland) · 2021Article
- Application of the Threshold of Toxicological Concern (TTC) in Food Safety: Challenges and Opportunities.Frontiers in toxicology · 2021Review
- Threshold of Toxicological Concern-An Update for Non-Genotoxic Carcinogens.Frontiers in toxicology · 2021Article
- Evaluation of the Suitability of MammalianFoods (Basel, Switzerland) · 2020Review
- Evaluating potential refinements to existing Threshold of Toxicological Concern (TTC) values for environmentally-relevant compounds.Regulatory toxicology and pharmacology : RTP · 2019Article
- Guidance on the use of the Threshold of Toxicological Concern approach in food safety assessment.EFSA journal. European Food Safety Authority · 2019Article
- Thresholds of Genotoxic and Non-Genotoxic Carcinogens.Toxicological research · 2018Review
- Utilizing Threshold of Toxicological Concern (TTC) with High Throughput Exposure Predictions (HTE) as a Risk-Based Prioritization Approach for thousands of chemicals.Computational toxicology (Amsterdam, Netherlands) · 2018Article
Corrections and comments
- Erratum issuedErratum.2017
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The threshold of toxicological concern (TTC) approach is a resource-effective de minimis method for the safety assessment of chemicals, based on distributional analysis of the results of a large number of toxicological studies. It is being increasingly used to screen and prioritize substances with low exposure for which there is little or no toxicological information. The first step in the approach is the identification of substances that may be DNA-reactive mutagens, to which the lowest TTC value is applied. This TTC value was based on the analysis of the cancer potency database and involved a number of assumptions that no longer reflect the state-of-the-science and some of which were not as transparent as they could have been. Hence, review and updating of the database is proposed, using inclusion and exclusion criteria reflecting current knowledge. A strategy for the selection of appropriate substances for TTC determination, based on consideration of weight of evidence for genotoxicity and carcinogenicity is outlined. Identification of substances that are carcinogenic by a DNA-reactive mutagenic mode of action and those that clearly act by a non-genotoxic mode of action will enable the protectiveness to be determined of both the TTC for DNA-reactive mutagenicity and that applied by default to substances that may be carcinogenic but are unlikely to be DNA-reactive mutagens (i.e. for Cramer class I-III compounds). Critical to the application of the TTC approach to substances that are likely to be DNA-reactive mutagens is the reliability of the software tools used to identify such compounds. Current methods for this task are reviewed and recommendations made for their application.
Indexed as
Identifiers
28510487What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.